Organizing Committee Member

Dr. Joel I.Osorio

Dr. Joel I.Osorio

President, CEO & Founder - Biotechnology, Regenerative Medicine
University of North Carolina at Chapel Hill


Dr.Osorio is the Founder, President, and CEO of RegenerAge Clinic and RegenerAge Beauty initiatives for transnational implementations. Vice President and International Clinical Developer for Bioquark, Inc. Chief Clinical Officer and Co-Founder at Reanima Advance Biosciences Project. Founder and CEO at the Dr. Jois® and BiorganicAging® initiatives and ™. Medical Advisor at The Cracking Monkey® and HairLogica®. Chief Medical Officer at What Skin Needs™/WSN International Pty. Ltd, Within the academic and educational fields, Dr. Osorio acts as the Executive Vice President: Chairman of the WAMS Americas Division, member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He also functions as the Chief Executive Officer and a Founder at The Reprogramming Medicine Association.

Research Area

Dr. Joel is the lead clinical developer for the Reanima Advance Biosciences Project and his passion for football, brought, as a result, the Dr. Jois Foundation A.C which helps those athletes who got injured to get another chance through the Regenerative and Reprogramming Medicine.

Talk to Us

Speak directly to one of our conference representatives by calling.

+44 8000 148923

Mail Us

E-mail us your questions about the conference. We will respond to your questions.

[email protected]

Contact Us

Have questions?
We'll be in touch within 24 hours.

Contact Us


EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.